Scientists have taken a major step towards developing a blood test that could identify millions of people who unknowingly spread tuberculosis.
Mar 22, 2024
0
72
Northwestern Medicine investigators led by Amy Heimberger, MD, Ph.D., the Jean Malnati Miller Professor of Brain Tumor Research and vice chair for Research in the Department of Neurological Surgery, have discovered a new ...
Mar 21, 2024
0
0
Microvillus inclusion disease (MVID) is a rare type of congenital enteropathy in infants that causes devastating diarrhea and an inability to absorb food. Infants can lose liters of fluid a day, become severely dehydrated, ...
Mar 6, 2024
0
0
In a finding that could help reduce the racial disparity in kidney disease, Duke Health researchers have detailed how two common gene variants among African Americans can cause kidney failure.
Feb 29, 2024
0
0
A new drug could offer a powerful way to sensitize tumors to immunotherapy, a new trial suggests. The results have been published in the Journal of Clinical Investigation.
Feb 27, 2024
0
1
When getting vaccines, switching arms for each dose may produce greater immunity than having the jabs delivered into the same arm.
Feb 6, 2024
0
26
Scientists led by a team at Duke-NUS Medical School have made a breakthrough in understanding the mechanisms that influence cancer cell growth and development. Publishing in the Journal of Clinical Investigation, the researchers ...
Feb 2, 2024
0
2
One of the major challenges in cancer research and clinical care is understanding the molecular basis for therapeutic resistance as a major cause of long-term treatment failures. In cases of melanoma, the main targeted therapeutic ...
Feb 1, 2024
0
0
While newly approved drugs for Alzheimer's show some promise for slowing the memory-robbing disease, the current treatments fall far short of being effective at regaining memory. What is needed are more treatment options ...
Feb 1, 2024
0
123
Currently used Food and Drug Administration-approved transplant drugs—with the addition of an also already FDA-approved complement inhibitor—are the optimal immunosuppression regimen for pig-to-human kidney transplants, ...
Jan 25, 2024
0
26
